Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia

Manuel Mattheisen; Thomas W. Mühleisen; Jana Strohmaier; Jens Treutlein; Igor Nenadic; Margrieta Alblas; Sandra Meier; Franziska Degenhardt; Stefan Herms; Per Hoffmann; Stephanie H. Witt; Ina Giegling; Heinrich Sauer; Thomas G. Schulze; Dan Rujescu; Markus M. Nöthen; Marcella Rietschel; Sven Cichon

doi:10.1016/j.schres.2012.08.027

Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia

Manuel Mattheisen, Thomas W. Mühleisen, Jana Strohmaier, Jens Treutlein, Igor Nenadic, Margrieta Alblas, Sandra Meier, Franziska Degenhardt, Stefan Herms, Per Hoffmann, Stephanie H. Witt, Ina Giegling, Heinrich Sauer, Thomas G. Schulze, Dan Rujescu, Markus M. Nöthen, Marcella Rietschel, Sven Cichon

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Convergent evidence from pharmacological and animal studies suggests a possible role for the synaptic vesicle glycoprotein 2A gene (. SV2A) in schizophrenia susceptibility. To test systematically all common variants in the SV2A gene region for an association with schizophrenia, we used a HapMap-based haplotype tagging approach and tested five SNPs in 794 patients and 843 controls. The SNP rs15931 showed evidence for an association with schizophrenia and was followed-up in an independent sample of 2581 individuals (overall p-value. =. 0.0042, OR. =. 0.779). Our study in the German population provides evidence, at a genetic level, for the involvement of the SV2A gene region in schizophrenia.

Original language	English
Pages (from-to)	262-265
Number of pages	4
Journal	Schizophrenia Research
Volume	141
Issue number	2-3
DOIs	https://doi.org/10.1016/j.schres.2012.08.027
Publication status	Published - Nov 2012
Externally published	Yes

Bibliographical note

Funding Information:
This study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of the German National Genome Research Network plus (NGFNplus) , and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to Sven Cichon and Markus M. Nöthen, grant 01GS08147 to Marcella Rietschel). This work was supported by grants U01 HL089856 , R01 MH087590 and R01 MH081862 . Igor Nenadic was supported by a Junior Scientist Grant of the IZKF, Medical School, Jena University Hospital . Igor Nenadic, Heinrich Sauer, Markus M. Nöthen, and Sven Cichon were additionally supported through an EU grant (EUTwinsS network, RTN, FP6). Jana Strohmaier was supported by the German Research Foundation ( GRK 793 ).

ASJC Scopus Subject Areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.schres.2012.08.027

Cite this

Mattheisen, M., Mühleisen, T. W., Strohmaier, J., Treutlein, J., Nenadic, I., Alblas, M., Meier, S., Degenhardt, F., Herms, S., Hoffmann, P., Witt, S. H., Giegling, I., Sauer, H., Schulze, T. G., Rujescu, D., Nöthen, M. M., Rietschel, M., & Cichon, S. (2012). Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia. Schizophrenia Research, 141(2-3), 262-265. https://doi.org/10.1016/j.schres.2012.08.027

Mattheisen, M, Mühleisen, TW, Strohmaier, J, Treutlein, J, Nenadic, I, Alblas, M, Meier, S, Degenhardt, F, Herms, S, Hoffmann, P, Witt, SH, Giegling, I, Sauer, H, Schulze, TG, Rujescu, D, Nöthen, MM, Rietschel, M & Cichon, S 2012, 'Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia', Schizophrenia Research, vol. 141, no. 2-3, pp. 262-265. https://doi.org/10.1016/j.schres.2012.08.027

@article{52c28f52959a4496bec9cd643dc0f7be,

title = "Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia",

abstract = "Convergent evidence from pharmacological and animal studies suggests a possible role for the synaptic vesicle glycoprotein 2A gene (. SV2A) in schizophrenia susceptibility. To test systematically all common variants in the SV2A gene region for an association with schizophrenia, we used a HapMap-based haplotype tagging approach and tested five SNPs in 794 patients and 843 controls. The SNP rs15931 showed evidence for an association with schizophrenia and was followed-up in an independent sample of 2581 individuals (overall p-value. =. 0.0042, OR. =. 0.779). Our study in the German population provides evidence, at a genetic level, for the involvement of the SV2A gene region in schizophrenia.",

author = "Manuel Mattheisen and M{\"u}hleisen, {Thomas W.} and Jana Strohmaier and Jens Treutlein and Igor Nenadic and Margrieta Alblas and Sandra Meier and Franziska Degenhardt and Stefan Herms and Per Hoffmann and Witt, {Stephanie H.} and Ina Giegling and Heinrich Sauer and Schulze, {Thomas G.} and Dan Rujescu and N{\"o}then, {Markus M.} and Marcella Rietschel and Sven Cichon",

note = "Funding Information: This study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of the German National Genome Research Network plus (NGFNplus) , and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to Sven Cichon and Markus M. N{\"o}then, grant 01GS08147 to Marcella Rietschel). This work was supported by grants U01 HL089856 , R01 MH087590 and R01 MH081862 . Igor Nenadic was supported by a Junior Scientist Grant of the IZKF, Medical School, Jena University Hospital . Igor Nenadic, Heinrich Sauer, Markus M. N{\"o}then, and Sven Cichon were additionally supported through an EU grant (EUTwinsS network, RTN, FP6). Jana Strohmaier was supported by the German Research Foundation ( GRK 793 ). ",

year = "2012",

month = nov,

doi = "10.1016/j.schres.2012.08.027",

language = "English",

volume = "141",

pages = "262--265",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier",

number = "2-3",

}

TY - JOUR

T1 - Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia

AU - Mattheisen, Manuel

AU - Mühleisen, Thomas W.

AU - Strohmaier, Jana

AU - Treutlein, Jens

AU - Nenadic, Igor

AU - Alblas, Margrieta

AU - Meier, Sandra

AU - Degenhardt, Franziska

AU - Herms, Stefan

AU - Hoffmann, Per

AU - Witt, Stephanie H.

AU - Giegling, Ina

AU - Sauer, Heinrich

AU - Schulze, Thomas G.

AU - Rujescu, Dan

AU - Nöthen, Markus M.

AU - Rietschel, Marcella

AU - Cichon, Sven

N1 - Funding Information: This study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of the German National Genome Research Network plus (NGFNplus) , and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to Sven Cichon and Markus M. Nöthen, grant 01GS08147 to Marcella Rietschel). This work was supported by grants U01 HL089856 , R01 MH087590 and R01 MH081862 . Igor Nenadic was supported by a Junior Scientist Grant of the IZKF, Medical School, Jena University Hospital . Igor Nenadic, Heinrich Sauer, Markus M. Nöthen, and Sven Cichon were additionally supported through an EU grant (EUTwinsS network, RTN, FP6). Jana Strohmaier was supported by the German Research Foundation ( GRK 793 ).

PY - 2012/11

Y1 - 2012/11

N2 - Convergent evidence from pharmacological and animal studies suggests a possible role for the synaptic vesicle glycoprotein 2A gene (. SV2A) in schizophrenia susceptibility. To test systematically all common variants in the SV2A gene region for an association with schizophrenia, we used a HapMap-based haplotype tagging approach and tested five SNPs in 794 patients and 843 controls. The SNP rs15931 showed evidence for an association with schizophrenia and was followed-up in an independent sample of 2581 individuals (overall p-value. =. 0.0042, OR. =. 0.779). Our study in the German population provides evidence, at a genetic level, for the involvement of the SV2A gene region in schizophrenia.

AB - Convergent evidence from pharmacological and animal studies suggests a possible role for the synaptic vesicle glycoprotein 2A gene (. SV2A) in schizophrenia susceptibility. To test systematically all common variants in the SV2A gene region for an association with schizophrenia, we used a HapMap-based haplotype tagging approach and tested five SNPs in 794 patients and 843 controls. The SNP rs15931 showed evidence for an association with schizophrenia and was followed-up in an independent sample of 2581 individuals (overall p-value. =. 0.0042, OR. =. 0.779). Our study in the German population provides evidence, at a genetic level, for the involvement of the SV2A gene region in schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=84866907367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866907367&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2012.08.027

DO - 10.1016/j.schres.2012.08.027

M3 - Article

C2 - 23017826

AN - SCOPUS:84866907367

SN - 0920-9964

VL - 141

SP - 262

EP - 265

JO - Schizophrenia Research

JF - Schizophrenia Research

IS - 2-3

ER -

Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia

Abstract

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this